Clinical Trials Directory

Trials / Completed

CompletedNCT01180452

Endoscopic Detection of Dysplasia in Crohn 's Disease Patient

Endoscopic Detection of Small Bowel Dysplasia and Cancer in Patients With Jejuna or Ileal Crohn Disease : Prospective Study in a Cohort of High Risk Patients

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
107 (actual)
Sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with Crohn's disease (CD) have an increased risk of small bowel adenocarcinoma (SBA). Long duration of CD is the main risk factor. SB dysplasia has been associated with SBA in 20% of cases, always described in diseased sites. The progression to neoplasia and natural history remains unknown but progression of inflammation to dysplasia and then to adenocarcinoma is suspected. As for surveillance recommendations for colorectal carcinoma in long standing inflammatory colonic disease, endoscopic screening of SB could be proposed in CD patients with risk factors of SBA. No study can be found in literature. The investigators propose a multicenter exploratory open study on prospective cohort of CD patients with high risk of dysplasia or cancer. The goal is evaluate the rate of dysplasia and adenocarcinoma detected by enteroscopy with biopsies in a high risk CD population

Conditions

Interventions

TypeNameDescription
PROCEDUREenteroscopyendoscopic enteroscopy to do biopsies on jejunum

Timeline

Start date
2010-01-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2010-08-12
Last updated
2015-06-23

Locations

15 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01180452. Inclusion in this directory is not an endorsement.